E, L., M, S., M, T., M, S., A, O., M, P., . . . F, C. (2026). The impact of tau deletion on Huntington's disease: An in vivo perspective. Molecular therapy : the journal of the American Society of Gene Therapy, 34(3), 1836. https://doi.org/10.1016/j.ymthe.2025.11.033
Chicago Style (17th ed.) CitationE, Lepinay, Saint-Pierre M, Teixeira M, Snapyan M, Oueslati A, Parent M, Alpaugh M, and Cicchetti F. "The Impact of Tau Deletion on Huntington's Disease: An in Vivo Perspective." Molecular Therapy : The Journal of the American Society of Gene Therapy 34, no. 3 (2026): 1836. https://doi.org/10.1016/j.ymthe.2025.11.033.
MLA (9th ed.) CitationE, Lepinay, et al. "The Impact of Tau Deletion on Huntington's Disease: An in Vivo Perspective." Molecular Therapy : The Journal of the American Society of Gene Therapy, vol. 34, no. 3, 2026, p. 1836, https://doi.org/10.1016/j.ymthe.2025.11.033.